Skip to content

Preferences for Over - the Counter Cough and Cold Medications

Effects of Pharmacological Attributes of Over - the Counter Medications on Preferences and Health Related Quality of Life in Subjects with Cough and Cold - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/088538
Enrollment
500
Registered
2025-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Indus Biotech Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects ready to sign the informed consent, who understand read and write in Marathi, Hindi, or English will be eligible to participate in the study 2. Subjects with the ability to complete the online/or face-to-face interview questionnaire independently or with the assistance of the investigator

Exclusion criteria

Exclusion criteria: 1. Subjects who were too sick physically for consultation, as judged clinically by the surveyors 2. Subjects unwilling to cooperate or participate, and not giving consent to participate in the survey

Design outcomes

Primary

MeasureTime frame
To identify the pharmacological attributes of OTC affecting the preferences for purchasing OTC products for cough and cold conditionTimepoint: Baseline

Secondary

MeasureTime frame
To study the effects of use of OTC medication on quality of life using validated Investigator-administered 36-Item Short Form Survey (SF-36) questionnaireTimepoint: Baseline;To study the prevalence (The prevalence of use of OTC drugs was determined as percentage of all users out of the total Sample) of use of OTC for cough & cold conditions.Timepoint: Baseline

Countries

India

Contacts

Public ContactNamrata Desai

Principal, SNJBs Shriman Sureshdada Jain College of Pharmacy

cdupasani@gmail.com9405663579

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026